Literature DB >> 33745011

Anabolic-androgenic steroid administration increases self-reported aggression in healthy males: a systematic review and meta-analysis of experimental studies.

Razieh Chegeni1, Ståle Pallesen2,3, Jim McVeigh4, Dominic Sagoe2.   

Abstract

RATIONALE: Aggression and irritability are notable psychiatric side effects of anabolic-androgenic steroid (AAS) use. However, no previous study has systematically reviewed and quantitatively synthesized effects reported by experimental studies on this topic.
OBJECTIVE: We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) investigating the effect of AAS administration on self-reported and observer-reported aggression.
METHODS: Twelve RCTs comprising a total of 562 healthy males were identified through systematic searches of MEDLINE, PsycInfo, ISI Web of Science, ProQuest, Google Scholar, and the Cochrane Library.
RESULTS: After excluding one outlier, AAS administration was associated with an increase in self-reported aggression under a random-effects model, albeit small (Hedges' g = 0.171, 95% CI: 0.029-0.312, k = 11, p = .018), and when restricting the analysis to the effect of acute AAS administration on self-reported aggression under a fixed-effect model (g = 0.291, 95% CI: 0.014-0.524, p = .014). However, the above effects were neither replicated in the analysis of observer-reported aggression nor after restricting the analysis to the effects of the administration of higher (over 500 mg) and long-term (3 days to 14 weeks) doses.
CONCLUSIONS: The present meta-analysis provides evidence of an increase, although small, in self-reported aggression in healthy males following AAS administration in RCTs. Ecologically rational RCTs are warranted to better explore the effect of AAS administration on aggression in humans.

Entities:  

Keywords:  Aggression; Anabolic-androgenic steroids; Meta-analysis; Randomized controlled trial

Mesh:

Substances:

Year:  2021        PMID: 33745011     DOI: 10.1007/s00213-021-05818-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  44 in total

1.  Standardization of the visual analogue scale.

Authors:  M E Cline; J Herman; E R Shaw; R D Morton
Journal:  Nurs Res       Date:  1992 Nov-Dec       Impact factor: 2.381

2.  An inventory for assessing different kinds of hostility.

Authors:  A H BUSS; A DURKEE
Journal:  J Consult Psychol       Date:  1957-08

Review 3.  Anabolic steroid abuse and dependence in clinical practice.

Authors:  Kirk J Brower
Journal:  Phys Sportsmed       Date:  2009-12       Impact factor: 2.241

4.  Oxymethalone and aggression.

Authors:  S Barker
Journal:  Br J Psychiatry       Date:  1987-10       Impact factor: 9.319

5.  Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.

Authors:  Aaron L Baggish; Rory B Weiner; Gen Kanayama; James I Hudson; Michael T Lu; Udo Hoffmann; Harrison G Pope
Journal:  Circulation       Date:  2017-05-23       Impact factor: 29.690

Review 6.  Behavioral and physiological responses to anabolic-androgenic steroids.

Authors:  Ann S Clark; Leslie P Henderson
Journal:  Neurosci Biobehav Rev       Date:  2003-08       Impact factor: 8.989

7.  The aggression questionnaire.

Authors:  A H Buss; M Perry
Journal:  J Pers Soc Psychol       Date:  1992-09

8.  Structural Brain Imaging of Long-Term Anabolic-Androgenic Steroid Users and Nonusing Weightlifters.

Authors:  Astrid Bjørnebekk; Kristine B Walhovd; Marie L Jørstad; Paulina Due-Tønnessen; Ingunn R Hullstein; Anders M Fjell
Journal:  Biol Psychiatry       Date:  2016-06-30       Impact factor: 13.382

9.  Anabolic-androgenic steroid use and involvement in violent behavior in a nationally representative sample of young adult males in the United States.

Authors:  Kevin M Beaver; Michael G Vaughn; Matt Delisi; John Paul Wright
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

10.  Case report: The long-term effects of anabolic steroids on the female voice over a 20-year period.

Authors:  Yael Bensoussan; Jennifer Anderson
Journal:  Clin Case Rep       Date:  2019-04-20
View more
  5 in total

1.  A Mixed-Method Evaluation of a Prison Anti-doping Intervention: The Hercules Prison Program.

Authors:  Dominic Sagoe; Berit Johnsen; Bo Lindblad; Tom Are Jensen Normann; Vidar Skogvoll; Morten Heierdal; Fredrik Lauritzen
Journal:  Front Sports Act Living       Date:  2021-12-23

Review 2.  The Role of Testosterone in the Elderly: What Do We Know?

Authors:  Biagio Barone; Luigi Napolitano; Marco Abate; Luigi Cirillo; Pasquale Reccia; Francesco Passaro; Carmine Turco; Simone Morra; Francesco Mastrangelo; Antonio Scarpato; Ugo Amicuzi; Vincenzo Morgera; Lorenzo Romano; Francesco Paolo Calace; Savio Domenico Pandolfo; Luigi De Luca; Achille Aveta; Enrico Sicignano; Massimiliano Trivellato; Gianluca Spena; Carlo D'Alterio; Giovanni Maria Fusco; Raffaele Vitale; Davide Arcaniolo; Felice Crocetto
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

3.  No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders.

Authors:  Julio X Amaral; Andrea C Deslandes; Monica C Padilha; Leonardo Vieira Neto; Luiz E Osorio; Francisco Radler Aquino Neto; Marcelo S Cruz
Journal:  Drug Test Anal       Date:  2022-02-21       Impact factor: 3.234

Review 4.  An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting.

Authors:  Adrian Sandra Dobs; Kevin James Campbell
Journal:  Int J Gen Med       Date:  2022-10-07

5.  Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis.

Authors:  Razieh Chegeni; Guy Notelaers; Ståle Pallesen; Dominic Sagoe
Journal:  Front Psychiatry       Date:  2021-06-04       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.